These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8337735)
1. Chemotherapy of Trypanosoma brucei infection of the central nervous system: the use of a rapid chemotherapeutic regimen and the development of post-treatment encephalopathies. Jennings FW; Hunter CA; Kennedy PG; Murray M Trans R Soc Trop Med Hyg; 1993; 87(2):224-6. PubMed ID: 8337735 [TBL] [Abstract][Full Text] [Related]
4. Future prospects for the chemotherapy of human trypanosomiasis. 2. Combination chemotherapy and African trypanosomiasis. Jennings FW Trans R Soc Trop Med Hyg; 1990; 84(5):618-21. PubMed ID: 2278054 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of CNS-trypanosomiasis: the combined use of the arsenicals and nitro-compounds. Jennings FW Trop Med Parasitol; 1991 Jun; 42(2):139-42. PubMed ID: 1896771 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of CNS-trypanosomiasis: combination chemotherapy with a 5-nitroimidazole (MK 436), an arsenical (Cymelarsan) and suramin. Jennings FW Trop Med Parasitol; 1991 Sep; 42(3):157-60. PubMed ID: 1801135 [TBL] [Abstract][Full Text] [Related]
7. Megazol combined with suramin improves a new diagnosis index of the early meningo-encephalitic phase of experimental African trypanosomiasis. Darsaud A; Chevrier C; Bourdon L; Dumas M; Buguet A; Bouteille B Trop Med Int Health; 2004 Jan; 9(1):83-91. PubMed ID: 14728611 [TBL] [Abstract][Full Text] [Related]
8. Trypanosoma brucei brucei: a long-term model of human African trypanosomiasis in mice, meningo-encephalitis, astrocytosis, and neurological disorders. Keita M; Bouteille B; Enanga B; Vallat JM; Dumas M Exp Parasitol; 1997 Feb; 85(2):183-92. PubMed ID: 9030668 [TBL] [Abstract][Full Text] [Related]
9. [Prophylactic and curative action of Ridzol-S and Ronidazole in experimental trypanosomiasis caused by Trypanosoma brucei et T. evansi]. Tchalim TK Ann Soc Belg Med Trop; 1980 Sep; 60(3):263-70. PubMed ID: 7195691 [No Abstract] [Full Text] [Related]
10. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study. Poltera AA; Hochmann A; Lambert PH Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886 [TBL] [Abstract][Full Text] [Related]
11. Immunopathological aspects of trypanosomal meningoencephalitis in vervet monkeys after relapse following Berenil treatment. Poltera AA; Sayer PD; Brighouse G; Bovell D; Rudin W Trans R Soc Trop Med Hyg; 1985; 79(4):527-31. PubMed ID: 4082265 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of RM110, a novel trypanocide, in the treatment of Trypanosoma evansi infections in camels. Zelleke D; Kassa B; Abebe S Trop Anim Health Prod; 1989 Nov; 21(4):223-6. PubMed ID: 2617676 [TBL] [Abstract][Full Text] [Related]
13. The use of 2-substituted 5-nitroimidazoles in the treatment of chronic murine Trypanosoma brucei infections with central nervous system involvement. Jennings FW; Urquhart GM; Murray PK; Miller BM Z Parasitenkd; 1984; 70(6):691-7. PubMed ID: 6524019 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of CNS-trypanosomiasis: the combined use of diminazene aceturate or pentamidine with DL-alpha-difluoromethylornithine (DFMO). Jennings FW Trop Med Parasitol; 1992 Jun; 43(2):106-9. PubMed ID: 1519020 [TBL] [Abstract][Full Text] [Related]
15. Relative efficacy of melarsen oxide compared with mel Cy (Cymelarsan) when used in combination with difluoromethylornithine in the treatment of trypanosomiasis of the central nervous system. Jennings FW Trans R Soc Trop Med Hyg; 1992; 86(3):257-8. PubMed ID: 1412647 [TBL] [Abstract][Full Text] [Related]
17. The European Medicines Agency's scientific opinion on oral fexinidazole for human African trypanosomiasis. Pelfrene E; Harvey Allchurch M; Ntamabyaliro N; Nambasa V; Ventura FV; Nagercoil N; Cavaleri M PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007381. PubMed ID: 31246956 [No Abstract] [Full Text] [Related]
18. DL-alpha-difluoromethylornithine (DFMO)-Berenil combination: therapeutic and prophylactic activity against Trypanosoma brucei brucei infection in mice. Onyeyili PA; Egwu GO; Zaria LT; Orjiude BA Rev Elev Med Vet Pays Trop; 1991; 44(4):443-5. PubMed ID: 1843826 [TBL] [Abstract][Full Text] [Related]
19. Development of Trypanosoma brucei in suckling mouse brain following intracerebral injection. Bafort JM; Schmidt H; Molyneux DH Trans R Soc Trop Med Hyg; 1987; 81(3):487-90. PubMed ID: 3686641 [TBL] [Abstract][Full Text] [Related]
20. Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes. Jennings FW; Gray GD Contrib Microbiol Immunol; 1983; 7():147-54. PubMed ID: 6825436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]